SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026227
Filing Date
2022-12-08
Accepted
2022-12-08 16:04:56
Documents
12
Period of Report
2022-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20221208.htm   iXBRL 8-K 51092
  Complete submission text file 0000950170-22-026227.txt   167428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytk-20221208_lab.xml EX-101.LAB 13474
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytk-20221208.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytk-20221208_pre.xml EX-101.PRE 9900
6 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20221208_htm.xml XML 4753
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 221452405
SIC: 2834 Pharmaceutical Preparations